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Syncope in the elderly is an extremely prevalent clinical condition characterized by high mortality and
presence of recurrences. The diagnosis of syncope in the elderly is sometimes difﬁcult and multidi-
mensional geriatric assessment should be carefully administered. Diagnostic algorithms should be
applied with attention, although unknown syncope is still frequent. The therapeutic approach to syncope
in the elderly is complicated by the high prevalence of neurally-mediated syncope, in which the ther-
apeutic approach is still unknown. The establishment of a “Syncope Unit” has certainly improved the
diagnostic-therapeutic approach to patients with syncope, especially in old age where the management
is extremely difﬁcult.
Copyright  2013, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license. 1. Introduction
Syncope is a symptom that consists of a "transient loss of con-
sciousness to spontaneous resolution, which usually leads to fall.
The relatively rapid onset and recovery, complete and spontaneous,
occurs in a short period of time”.1 The classiﬁcation of syncope is
shown in Table 1. The pathophysiological mechanism underlying
syncope is a transient global cerebral hypoperfusion. Any loss of
consciousness, even transitory, that does not accurately reﬂect
these characteristics, must be considered as a “pseudo-syncope”.
Some pathological conditions, in fact, such as epilepsy, disorders of
metabolism (hypoxia and hypoglycemia), and poisoning are char-
acterized by a loss of consciousness, but in the absence of cerebral
hypoperfusion (Table 2).2. Epidemiology of syncope in the elderly
Syncope is a clinical condition of great interest in the geriatric
population, due to its high prevalence and signiﬁcant morbidity.2ediche Traslazionali, Cattedra
apoli, Italy.
linical Gerontology & Geriatrics. PApproximately 3% of urgent visits to the emergency department
and 2e6% of hospital admissions, are due to syncope or trauma and
these patients are aged 65 years or older in 80% of cases.1 A recent
analysis of data from the Framingham study shows that the inci-
dence of syncope increases exponentially in the elderly and in
particular in the 8th decade and 9th decade of life. The incidence of
syncope increased from 5.7 per 1000 patients per year in the 7th
decade to 19.5 per 1000 patients per year in the 9th decade.2 Hip
fractures are one of the most feared consequences of syncope in the
elderly, as well as the reduction of functional capacity and insti-
tutionalization.3 The mortality for syncope in the elderly, however,
ranges between 30% and 50% according to the observation time of
follow-up (2e5 years) with a frequency of recurrences in a variable
range between 25% and 30%.4
3. The diagnosis of syncope in the elderly
A previous estimate to the year 2000 indicated that the
prevalence of syncope of unknown origin exceeded 40%.5 This is
due to the fact that for elderly patients, some diagnostic pro-
cedures, such as the tilt table test and carotid sinus massage, had
been banned as a result of a controversial danger. The Italian
Group for the Study of Syncope in the elderly (GIS) has veriﬁedublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1
Classiﬁcation of syncope according to the guidelines of the European Society of Cardiology.
Neurally-mediated Vasovagal Mediated by emotional stress
Mediated by orthostatic stress
Situational Cough, sneeze
Gastrointestinal situation (swallow, defecation, etc.)
Micturition
Postexercise
Postprandial
Others (e.g., laugh)
Carotid sinus syncope
Atypical forms (without apparent trigger)
Orthostatic hypotension Primary autonomic failure Parkinson’s disease, Lewy body dementia, etc.
Volume depletion Hemorrhage, diarrhea, etc.
Drug-induced hypotension Alcohol, vasodilators, diuretics, etc.
Secondary autonomic failure Diabetes, amyloidosis, etc.
Cardiac syncope Arrhythmias Bradycardia
Tachycardia
Drug-induced bradycardia or tachycardia
Structural disease Cardiac: valvular disease, acute myocardial infarction, etc.
Others: pulmonary embolism, acute aortic dissection, etc.
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geriatric population.6 The GIS, by applying the diagnostic algo-
rithm of the European Society of Cardiology (ESC),1 performed a
diagnostic screening in a geriatric population (Fig. 1). This
approach reveals many of those cases considered to be due to
unexplained syncope, reducing the prevalence of these to only
10% (Fig. 2).7 The neurally-mediated syncope was considered,
until recently, the prerogative of the young adult population and
the syncope of cardiac origin were mainly attributed to geriatric
age. The data from GIS have clearly indicated the prevalence of
neurally-mediated syncope in the elderly (70%) compared to
those of a cardiac origin (20%) (Fig. 2).6,7
4. The diagnostic algorithm of syncope: First level evaluation
The initial approach to an elderly patient with syncope should
take into account three main questions, which should guide the
whole diagnostic process: (1) has the loss of consciousness a
syncopal origin, or is it a syncope-like condition?; (2) is there heart
disease?; and (3) how is the history of syncope? Once detected, the
likely origin of syncopal transient loss of consciousness is deter-
mined through the initial assessment as the key moment in the
diagnosis of syncope, especially in elderly patients: this include a
history, a physical examination including an orthostatic hypoten-
sion test, and an electrocardiogram (ECG), which very often fails to
make a diagnosis certain or highly suspect. It is worth emphasizing
the importance of the orthostatic hypotension test that too often is
not carried out, especially in the elderly: in these patients, in fact,
orthostatic syncope has a very high prevalence. The basic purpose
of the ﬁrst level evaluation is to identify patients at risk for
cardiogenic syncope, which always has a worse prognosis than the
other causes, regardless of age.2e4Table 2
Pseudo-syncope according to the guidelines of the European Society of Cardiology.
With loss of consciousness Epilepsy
Metabolic disorders (hypoxia, hypoglycemia,
hypocapnia by hyperventilation)
Poisoning
Vertebrobasilar transient ischemic attack
Without loss of consciousness Falls
Cataplexy
Drop attacks
Carotid transient ischemic attack5. Risk stratiﬁcation in the diagnosis of syncope
A score to predict the risk of cardiac syncope and mortality from
the initial assessment was recently validated as derived from the
results of the study “Evaluation of Guidelines in SYncope Study 2”
(EGSYS 2).8 The EGSYS 2 risk score is a method of risk stratiﬁcation
that considers independent clinical predictors of cardiogenic syn-
cope: the abnormal ECG and/or the presence of heart disease, the
presence of palpitations prior to syncope, a syncopal episode during
exertion or supine, the absence of neuroautonomic prodromes, and
the absence of precipitating and/or predisposing factors. To each of
these variables a score is assigned; a total score of three or more is
an indicator of cardiogenic syncope. Thus, prodromal symptoms
seem to represent a critical point of syncope diagnosis. However,
the GIS study has given us important information about the pre-
syncopal prodromal symptoms in the elderly which can predict the
type of syncope and address the early diagnosis towards cardiac or
non-cardiac etiology. In particular, the presence of nausea, blurred
vision, sweating, and premonition of fainting directs the diagnostic
suspicion towards a non-cardiac syncope, whereas the presence of
dyspnea points towards a cardiac syncope.9Fig. 1. Diagnostic algorithm according to the European Society of Cardiology.
* High risk patients need early evaluation treatment.
Fig. 2. Prevalence of syncope diagnosis from 1986 to 2006.
Fig. 3. Sometimes elderly individuals with syncope slump in a chair and this may
delay laying them ﬂat.
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Elderly people are at highest risk of acquired disability, cogni-
tive decline, or admission to residential care, either as a conse-
quence of illness, or as an unfortunate consequence of treatment.
Therefore, older people’s needs are more complex, with potentially
coexistent medical, functional, psychological, and social needs. This
can lead to an atypical presentation that can often be misunder-
stood and requires a different approach to care.10 One of the cor-
nerstones of modern geriatric care is the comprehensive geriatric
assessment (CGA), which is both a diagnostic and therapeutic
process and ensures that problems are identiﬁed, quantiﬁed, and
managed appropriately. Usually, patients are cared for by the
specialist team, who provide a geriatric evaluation. In a recent
meta-analysis 22 randomized controlled trials (10,315 participants)
of CGA (whether by mobile teams or in designated wards)
compared with usual care were analyzed; patients who underwent
CGAwere more likely to be alive and in their own homes at the end
of scheduled follow-up [odds ratio 1.16 (95% conﬁdence interval
1.05e1.28); p ¼ 0.003].11
The importance of a CGA, therefore, becomes essential in the
elderly. Recently, the GIS group published an extremely paradig-
matic clinical case, which describes the “apparently” accidental fall
of the elderly. In fact, the case highlights how in the elderly it is
essential to perform the multidimensional geriatric assessment
that must accompany and/or precede the application of the diag-
nostic algorithm of syncope. It is well known that the multidi-
mensional geriatric evaluation by investigating the elderly
individual in their entirety, especially with regard to the cognitive,
depressive, and self-sufﬁciency aspects, is able to highlight psycho-
physical impairments very often underestimated. The described
elderly individual says he feels sliding, minimizing the incident (as
often happens in the elderly). Multidimensional evaluation, how-
ever, showed a cognitive impairment that subsequent in-
vestigations correlated to the presence of vascular dementia. The
history, therefore, was not likely in this individual and, in fact, the
application of the diagnostic algorithm highlighted a sinus node
disease that led to a syncopal episode during stimulation of the
carotid sinus. In this patient an indication for implantation of a
cardiac stimulator was found and follow-up over time showed no
more episodes of falling and/or syncope.12
Another important aspect of syncope in the elderly is the very
frequent condition of disability that leaves the patient unable to
stand. Therefore, the risk of permanent brain damage during hy-
potensive syncope is high in elderly people. A person suffering from
‘‘shock’’ and hypotension should immediately be laid ﬂat on the
ﬂoor to improve blood ﬂow to the brain. By contrast, sometimeselderly individuals with syncope are slumped in a chair and this
condition may delay laying the person ﬂat. A delay is especially
likely in a nursing home, if a resident is sitting in a wheelchair off
his or her nursing unit (Fig. 3).13
7. The diagnostic algorithm of syncope: Second level
investigations
The initial evaluation can suggest a preliminary diagnostic
orientation and, therefore, select the second level investigations.
Only when the initial assessment suggests “pseudo-syncope”
diagnostic tests, such as a cerebral computed tomography, a
Doppler ultrasound of the carotid vessels, or an electroencephalo-
gram should be performed. In particular, the CT scan should be
performed only in the presence of head injury secondary to the fall,
as the electroencephalogram, simple or after sleep deprivation,
should be reserved only for patients with suspected epileptic na-
ture of loss of consciousness.1
8. Suspected diagnosis of cardiac syncope
When in the initial assessment there are elements which lead
to a syncope of cardiac origin, echocardiography is mandatory and
crucial, especially in the presence of aortic stenosis, a dilated or
hypertrophic cardiomyopathy, and a pulmonary embolism. In pa-
tients with suspected arrhythmic etiology, who have frequent
episodes of loss of consciousness or palpitations shortly prior to a
syncope episode, only rarely is a dynamic ECG Holter electrocar-
diogram diagnostic. The ECG Holter, in fact, is diagnostic only in
the rare cases in which an event occurs during syncope or pre-
syncope during recording. The presence of a causal association
between arrhythmia and symptoms has been demonstrated only
rarely; this test may be useful in patients with psychogenic
syncope d the demonstration of a normal rhythm during the loss
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a real syncope.1 An electrophysiological study is indicated in all
cases in which the initial assessment is suggestive of an
arrhythmic cause, such as the presence of heart disease in the
clinical history, the presence of electrocardiographic abnormal-
ities, prodromal symptoms characterized by palpitations, and/or a
family history of sudden cardiac death. An exercise test is indi-
cated in the case of syncope on exertion, when there is a suspicion
of ischemic heart disease. In carefully selected cases in which the
suspicion of ischemic syncope is very strong (e.g., in the presence
of several risk factors for coronary artery disease and in the
absence of other plausible causes of syncope) coronary angiog-
raphy may be indicated.1
9. Suspected diagnosis of neurally-mediated syncope
When the initial investigation, however, oriented towards a
neurally-mediated syncope, as well as when the ﬁrst-level tests
are negative, the diagnostic procedure involves the carotid sinus
massage in supine and standing positions, the Tilt Table Test
(TTT)14 and, in selected cases, ambulatory monitoring of blood
pressure over 24 hours, which is especially useful in the case of
postprandial or night hypotension. Carotid sinus massage should
be performed only by an experienced physician with electrocar-
diogram control and after objective and/or sonographic exclusion
of carotid atherosclerosis. Contraindications to carotid sinus
massage are the presence of carotid bruits, recent myocardial or
cerebral ischemia, or previous ventricular tachyarrhythmias.15 The
TTT is the test of greater clinical use for the evaluation of neuro-
mediated reﬂexes. In particular, it is the reference test for the
diagnosis of neurally mediated syncope in all cases of syncope of
unknown origin found on a ﬁrst level analysis (after the exclusion
of an organic heart disease on the basis of clinical history, physical
examination, and ECG). There are several protocols for the per-
formance of the TTT, but the most popular is enhanced with
nitroglycerin, also validated in the elderly by the GIS.6 In Table 3,
the various types of response to TTT are indicated: only in the
response 2B (heart rate reduction with asystole > 3 seconds)
is there a relative indication to the implantation of a cardiac
stimulator (Table 3).1 The carotid sinus massage is the other
instrumental examination of great importance in the diagnosis of
neurally-mediated syncope in the elderly; the ESC guidelines
propose its performance in examinations of the ﬁrst level, given
the high prevalence of carotid-sinus syndrome as a cause of
unexplained syncope and falls in this age group (in patients over
85 years old the test was positive in 68% of cases).15,16
10. Orthostatic syncope
Orthostatic hypotension, and related-orthostatic syncope are
frequent clinical problems among elderly patients, associated with
signiﬁcant morbidity and mortality.17 Acute orthostatic hypoten-
sion is usually secondary to medication, ﬂuid or blood loss, or ad-
renal insufﬁciency. By contrast, chronic orthostatic hypotension is
frequently due to altered blood pressure regulatory mechanisms
and autonomic dysfunction. In the elderly, diagnostic evaluationTable 3
Different responses to Tilt Table Test.
Response Arterial pressure Heart rate
VASIS 1 Y Y >10% (40 bpm > 10 s)
VASIS 2A Y Y with asystole  3 s
VASIS 2B Y Y with asystole > 3 s
VASIS 3 Y Y 10%requires a CGA, with particular attention to symptoms of auto-
nomic nervous system dysfunction, careful blood pressure mea-
surement at various times of the day and after meals or
medications, and laboratory studies.17 Recently, in a case-control
study enrolling 1000 elderly patients, the prevalence of ortho-
static hypotension (OH) decreased (from 35.0% to 28.0%) in the CGA
intervention group, whereas its prevalence increased in the control
group (from 32.8% to 40.8%).18 It is very important to exclude di-
agnoses of neurodegenerative diseases, amyloidosis, diabetes,
anemia, and vitamin deﬁciency as causes of orthostatic hypoten-
sion. Elderly patients with symptoms often beneﬁt from a stepped
approachwith initial non-pharmacological interventions, including
avoidance of potentially hypotensive medications and the use of
physical counter maneuvers. Successively, several pharmacother-
apeutic agents can be added, including vagolytic substances, such
as disopyramide, ﬂudrocortisone, midodrine, and nonsteroidal
anti-inﬂammatory drugs. With a correct evaluation and manage-
ment, the occurrence of adverse events, including falls, fractures,
functional decline, and myocardial ischemia, can be signiﬁcantly
reduced.17 Finally, the association of clinostatic hypertension and
orthostatic hypotension described as the "Hyp-Hyp phenomenon,"
has been found in up to 50% of patients with orthostatic hypoten-
sion. The importance of clinostatic hypertension/orthostatic hy-
potension in clinical practice is mainly due to the presence of
troublesome symptoms, end-organ damage, and difﬁculties in its
clinical management.19
11. Syncope with undetermined etiology
As mentioned above, unknown etiology remains in at least 10%
of all cases of syncope in the elderly.7 A large number of diagnostic
tests were undertaken in patients with unexplained syncope,
without providing conclusive data. By contrast, the Implantable
Loop Recorder (ILR) revealed or contributed in establishing the
mechanism of syncope in the vast majority of patients. The ILR is a
recorder that is implanted under the skin with a simple minimally
invasive procedure. It has a memory duration of 36 months and
allows evaluation of the heart rhythm at the time of syncope. The
unit has an internal memory capable of recording arrhythmic
events, either automatically or after activation by the patient at
the onset of the prodrome, or after the resumption of conscious-
ness. The ILR is implanted with the following indications: (1)
when, after various assessments, the mechanism of syncope re-
mains unclear in patients with symptoms and ECG suggesting
arrhythmic origin of syncope; and (2) in patients with recurrent
syncope associated with trauma.20 The ﬁndings support the
recommendation in current guidelines that an ILR should be
implanted earlier rather than late in the evaluation of unexplained
syncope.
12. Treatment of syncope in the elderly
A proper treatment of syncope in the elderly requires an accu-
rate diagnosis. In cardiac syncope, both with organic disease (e.g.,
severe aortic stenosis) and arrhythmias (e.g., sinus node disease),
the therapeutic indication is unique: valve replacement in the case
of aortic stenosis and cardiac stimulator in case of sinus node
disease.1
The treatment of neurally-mediated syncope in elderly patients,
however, deserves particular attention,. In this regard, it should be
stressed that this type of patient presents age-related alterations
that make one more vulnerable to this type of syncope and which
may signiﬁcantly inﬂuence the effectiveness of therapeutic aids
adopted.7,9 The classic dietary and behavioral approaches indicated
in the treatment of neurally mediated syncope (to avoid extreme
Fig. 4. Syncope Unit as a central point of management of syncope in the elderly.
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increase ﬂuid intake and salt, to use elastic stockings, to make
counter-pressure maneuvers), sometimes overlooked, are to be
used early in the elderly.1 Moderate exercise, combined with a ﬁxed
position during sleep (inclination of 10), or periods of tilt-training,
have provided conﬂicting data in preventing or reducing the
syncopal episodes in the elderly. The drug history plays a key role in
the management of elderly patients: the use of diuretics, vasodi-
lators, drugs, and beta-blockers can, in fact, further and/or cause
syncope.1 Sympathomimetic drugs such as midodrine (Gutron),
methylphenidate (Ritalin) and etilefrine (Effortil) were completely
ineffective in the treatment of vasovagal syncope.21 Similarly, beta-
blockers are not effective, whereas antidepressants such as parox-
etine (Seroxat) achieved signiﬁcant results, even if the data has not
been conﬁrmed yet. In some selected cases, the effectiveness of
disopyramide (Ritmodan), an antiarrhythmic drug with anticho-
linergic effects, in the prevention of neurally mediated syncope, has
been demonstrated. Finally, ﬂudrocortisone (Florinef), a cortico-
steroid with marked sodium-retentive activity, has been used
successfully in recurrent neurally-mediated syncope.21
The efﬁcacy of cardiac pacing in preventing syncopal re-
currences in patients with neurally-mediated syncope is contro-
versial. In the Third International Study on Syncope of Uncertain
Etiology (ISSUE-3) trial, patients older than 40 years that experi-
enced3 syncopal episodes in the previous 2 years were studied.22
The 2-year estimated syncope recurrence rate was 57% with
pacemaker OFF and 25% with pacemaker ON. The risk of recurrence
was reduced by 57%. Thus, dual-chamber permanent pacing is
effective in reducing recurrence of syncope in patients 40 years
old with severe asystolic neurally-mediated syncope and 57%
reduction in syncope recurrence supports this invasive treatment
for the relatively benign neurally mediated syncope.22
Finally, the treatment of syncope in old age, especially neurally-
mediated treatment, is accomplished through a “multiple”
approach in order to resolve the various pathogenetic components
characteristic of the elderly patient.23
13. The syncope unit
Recently, due to the complexity in managing patients with syn-
cope, who often undergo expensive and inappropriate tests that
prolong hospitalization, and increase health spending without
reaching a correct diagnosis, the “Syncope Unit” was established.The Syncope Unit is a functional organization with various areas of
multidisciplinary expertise within the hospital. When present, pa-
tients with syncope access the Syncope Unit after the assessment of
theﬁrst level did not clarify the etiologyof the syncope or thosewith
speciﬁc risk conditions. This scenario is very frequent in elderly
patients with syncope (Fig. 4).1 The coordination of the activities of
the Syncope Unit must be carried out by medical staff who have
extensive experience in transient loss of consciousness and have full
access to all diagnostic and therapeutic procedures (geriatrician,
cardiologist, emergency physician, internist, neurologist). This
structure allowed the reduction of incongruous tests, such as cere-
bral CT scans, electroencephalography with an effective contain-
ment of healthcare costs, and an improved diagnostic accuracy.24,25
14. Conclusions
Syncope in the elderly is extremely prevalent and is character-
ized by high mortality and the presence of recurrences. The deﬁ-
nition of the cause of syncope in the elderly is not easy, but it can be
improved with careful consideration of the history and with the
multidimensional geriatric assessment. The therapeutic approach
to syncope in the elderly is complicated by the high prevalence of
neurally-mediated syncope, the treatment of which is not well
deﬁned yet. The establishment of a "Syncope Unit" has certainly
improved the diagnostic-therapeutic approach to patients with
syncope, especially in old age, where management becomes
extremely complex.
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